SUPRIYANSESupriya Lifescience LimitedMinimalNeutral
Announced Wed, 11 Mar · 23:56 IST

Supriya Lifescience Limited has informed the Exchange about Copy of Newspaper Publication of Postal Ballot Notice dispatched to the shareholders

SUPRIYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Supriya Lifescience Limited has published its Postal Ballot Notice in Financial Express (English) and Loksatta (Marathi) on March 11, 2026, seeking shareholder approval through remote e-voting on three special resolutions. The resolutions cover the appointment of Mr. Manish Panchal (DIN: 08431492) and Mr. Kothandaramen Hari (DIN: 08901674) as new Non-Executive Independent Directors for 5-year terms beginning February 9, 2026, and the re-appointment of Dr. Neelam Arora (DIN: 01603066) as Non-Executive Independent Director for a second 5-year term from March 25, 2026 to March 24, 2031. The e-voting window runs from March 11, 2026 (9:00 a.m.) to April 10, 2026 (5:00 p.m.) via NSDL, with February 27, 2026 set as the cut-off date for eligibility. CS Sanam Umbargikar has been appointed as scrutinizer to oversee the process in a fair and transparent manner.

Likely market impact

This is a routine corporate governance exercise to formalize board changes through shareholder approval. There is no direct financial impact on shareholders, but the outcome will shape the composition of the company's board over the next five years once voting closes on April 10, 2026.